Orthex (ORTHEX) Q1 2025 earnings summary

Executive summary

• Net sales declined 4.7% year-over-year to EUR 21.0 million in Q1 2025, impacted by weak consumer sentiment, macroeconomic uncertainty, and strikes in Finland.

• Adjusted EBITA fell 37.9% to EUR 1.7 million, with margin dropping to 8.2% from 12.6% a year earlier.

• Cash flow from operating activities improved to EUR 4.7 million, and the balance sheet remains healthy, supporting future investments.

• Strategic priorities include strengthening the Nordic market, expanding in Europe, and increasing the share of sustainable products.

• Focus remains on cost control, innovation, and sustainability despite challenging market conditions.

Financial highlights

• Net sales: EUR 21.0 million (down 4.7% year-over-year); constant currency sales declined 4.8%.

• Adjusted EBITA: EUR 1.7 million (down 37.9% year-over-year); margin 8.2%.

• Gross margin: 27.7% (down from 30.4%); earnings per share: EUR 0.07 (down from EUR 0.09).

• EBITDA: EUR 2.9 million (down 23.4%); EBITDA margin 14.0%.

• Net cash flows from operating activities: EUR 4.7 million (up 14.6% year-over-year).

Outlook and guidance

• The company remains committed to its long-term financial targets, though Q1 results were below expectations.

• Market environment remains uncertain with low consumer confidence and ongoing geopolitical risks.

• Management expects continued challenging consumer sentiment and is focused on sales growth as the main lever for profit improvement.

• Long-term targets: annual organic net sales growth >5% (currently -4.7%), EBITA margin >18% (currently 8.2%), leverage <2.5x (currently 1.2x), and pay-out ratio >50% (currently 63.9%).

• A strategy review is underway, but targets remain unchanged for now.